Patient Preferences for Stroke Outcomes

In clinical trials stroke is reported as a major morbid outcome, but the impact of stroke on patients is not directly assessed. This study examines patient preferences for different outcomes of stroke, including death. Methods We presented patients with written case scenarios of stroke outcomes. The scenarios represented four categories of stroke severity (mild, moderate, severe, and fatal), and for nonfatal strokes the scenarios described motor, language, and cognitive deficits. Patients reported values for each of the 10 stroke scenarios using a rank-and-scale method over a 100-point range, with 100 representing perfect health and 0 corresponding to the worst possible health state. Results One hundred seventeen of 209 consecutive patients at risk for stroke participated in this study. Severe strokes were uniformly rated as having low preference weights (mean±SD [median]: 3±4 [1] for disabling hemiplegia, 8±9 [5] for confusion, and 15 ±14 [10] for global aphasia), and severe motor impairment (a disabling hemiplegia) was rated as significantly worse than death. Even mild deficits resulted in substantial loss to patients (54±21 [55] for dysarthria and 53±21 [50] for mild anomia). Conclusions Strokes may result in a wide variety of poststroke consequences for patients. Severe strokes may be viewed by patients as tantamount to or worse than death. Even mild strokes may cause significant declines in patient preferences for health states. These data are useful in interpreting studies that report stroke and death, in designing new studies that measure stroke in at-risk populations, and in helping patients reach treatment decisions about therapies designed to prevent strokes.

[1]  K McPherson,et al.  Clinical decision-making. , 1980, Social science & medicine. Medical economics.

[2]  R G Robinson,et al.  Post‐stroke depressive disorders: a follow‐up study of 103 patients. , 1982, Stroke.

[3]  T. Theorell,et al.  Disablement and Quality of Life After Stroke , 1984, Stroke.

[4]  R L Hewer,et al.  Functional abilities after stroke: measurement, natural history and prognosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  S. Pauker,et al.  Endarterectomy in carotid artery disease. A decision analysis. , 1987, JAMA.

[6]  M L Niemi,et al.  Quality of life 4 years after stroke. , 1988, Stroke.

[7]  V. E. Smirnov,et al.  Results of the seven-year prospective study of stroke patients. , 1988, Stroke.

[8]  M. Viitanen,et al.  Life satisfaction in long-term survivors after stroke. , 1988, Scandinavian journal of rehabilitation medicine.

[9]  Endarterectomy in carotid artery disease. A decision analysis: Matchar DB, Pauker SG. JAMA 1987;258:793-8 , 1988 .

[10]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[11]  Lippincott Williams Wilkins,et al.  Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. The Asymptomatic Carotid Atherosclerosis Study Group. , 1989, Stroke.

[12]  R. Keith Status of Measurement in Stroke Rehabilitation Outcomes , 1990, Stroke.

[13]  Current Use of Functional Assessment to Measure Stroke Outcome in Canada , 1990, Stroke.

[14]  J. Williams,et al.  Examining outcome measures in a clinical study of stroke. , 1990, Stroke.

[15]  Bernard Rosner,et al.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[16]  N. Chino Efficacy of Barthel Index in Evaluating Activities of Daily Living in Japan, the United States, and United Kingdom , 1990, Stroke.

[17]  C. Warlow,et al.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis , 1991, The Lancet.

[18]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[19]  Ralph G. Dacey,et al.  Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis , 1991 .

[20]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[21]  L. Wilkins Carotid Surgery Versus Medical Therapy in Asymptomatic Carotid Stenosis , 1991, Stroke.

[22]  G. Albers,et al.  Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials , 1991, Annals of neurology.

[23]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[24]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[25]  A S Detsky,et al.  Treatment of Chronic Nonvalvular Atrial Fibrillation in the Elderly , 1992, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  S. Pauker,et al.  Decision analytic and cost-effectiveness issues concerning anticoagulant prophylaxis in heart disease. , 1992, Chest.

[27]  G. Sicard MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or mild (0–29%) carotid stenosis: European Carotid Surgery Trialist' Collaborative Group. Lancet 1991;337:1235-43 , 1992 .

[28]  I. Sand Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk , 1992, Annals of Internal Medicine.

[29]  A. Stewart,et al.  Measuring Functioning and Well-Being: The Medical Outcomes Study Approach , 1992 .

[30]  S. Pauls The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment: Maggioni AP, Franzosi MG, Santoro E, et al N Engl J Med 327:1–6 Jul 1992 , 1992 .

[31]  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993 .

[32]  W S Moore,et al.  Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. , 1993, The New England journal of medicine.

[33]  J B Tomblin,et al.  Clinical decision making: describing the decision rules of practicing speech-language pathologists. , 1994, Journal of speech and hearing research.

[34]  Bruce Kinosian,et al.  Decision Analytic Modeling: Some Uses in the Evaluation of New Pharmaceuticals , 1994 .